Concord Biotech Ltd. Earnings/Conference Calls

Concord Biotech Ltd.

NSE: CONCORDBIO | BSE: 543960

Expensive Performer

Download real time

1752.00 85.10 (5.11%)

High volume+gain today

NSE 30 May, 2025 3:30 PM (IST)

18,328.8

Market Cap

Market Runner Up

0.7

Beta 1Year

Very Low volatility

Estimates Beat

Concord Biotech's Q4 profit and revenue beat Forecaster estimates by 22.9% and 14.9%, respectively See details

Concord Biotech Ltd. earnings concalls and investor presentations

Load latest

Concord Biotech Ltd.

07 Sep 2023

1752.00

5.11%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, and further to our intimation dated September 01, 2023 to the exchange regarding Earning call in respect of the Unaudited Financial Results of the company for the Quarter ended June 30, 2023, we wish to inform that the said Earning Call was held today at 4:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q1FY24-Earnings-call.mpeg Kindly take the above on records.

pdf

Concord Biotech Ltd.

06 Sep 2023

1752.00

5.11%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, a results presentation to analyst/investor for the period ended June 30, 2023 is enclosed. Kindly take the above on records.

pdf

34.23% Fall from 52W High

High volume+gain today

Concord Biotech Ltd. Earnings/Conference Calls

Concord Biotech Ltd. earnings concalls and investor presentations